Cargando…
Systemic lupus erythematosus and glycation process
Systemic lupus erythematosus (SLE) is a disease of unclear causes, which leads to major immunological disorders. It is characterized by an abnormal immune system activity resulting in the production of autoantibodies. In patients, antibodies targeting normal nuclear components, double-stranded DNA (...
Autores principales: | NOWAK, AGNIESZKA, PRZYWARA-CHOWANIEC, BRYGIDA, TYRPIEń-GOLDER, KRYSTYNA, NOWALANY-KOZIELSKA, EWA |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226551/ https://www.ncbi.nlm.nih.gov/pubmed/32425686 http://dx.doi.org/10.5114/ceji.2018.77875 |
Ejemplares similares
-
Advanced Glycation End-Products (AGEs) and Their Soluble Receptor (sRAGE) in Women Suffering from Systemic Lupus Erythematosus (SLE)
por: Nowak, Agnieszka, et al.
Publicado: (2021) -
Systemic Lupus Erythematosus, Its Impact on Selected Cardiovascular Risk Factors, and Correlation with Duration of Illness: A Pilot Study
por: Przywara-Chowaniec, Brygida, et al.
Publicado: (2020) -
The effects of glucocorticoid treatment on cardiovascular system in patients with systemic lupus erythematosus
por: Blachut, Dominika, et al.
Publicado: (2022) -
Evaluation of the intima-media complex in patients with systemic lupus erythematosus
por: Przywara-Chowaniec, Brygida, et al.
Publicado: (2014) -
Update of Potential Biomarkers in Risk Prediction and Monitoring of Atherosclerosis in Systemic Lupus Erythematosus to Prevent Cardiovascular Disease
por: Blachut, Dominika, et al.
Publicado: (2023)